Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IM Cannabis (IMCC) Cash & Current Investments (2019 - 2025)

Historic Cash & Current Investments for IM Cannabis (IMCC) over the last 7 years, with Q3 2025 value amounting to $1.7 million.

  • IM Cannabis' Cash & Current Investments rose 1721.92% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year increase of 1721.92%. This contributed to the annual value of $677080.3 for FY2024, which is 4961.2% down from last year.
  • According to the latest figures from Q3 2025, IM Cannabis' Cash & Current Investments is $1.7 million, which was up 1721.92% from $601908.2 recorded in Q2 2025.
  • Over the past 5 years, IM Cannabis' Cash & Current Investments peaked at $27.7 million during Q2 2021, and registered a low of $601908.2 during Q2 2025.
  • For the 5-year period, IM Cannabis' Cash & Current Investments averaged around $5.7 million, with its median value being $1.8 million (2023).
  • Per our database at Business Quant, IM Cannabis' Cash & Current Investments surged by 6200.15% in 2021 and then crashed by 8365.9% in 2022.
  • Quarter analysis of 5 years shows IM Cannabis' Cash & Current Investments stood at $11.0 million in 2021, then crashed by 83.66% to $1.8 million in 2022, then dropped by 26.19% to $1.3 million in 2023, then plummeted by 50.17% to $663592.2 in 2024, then skyrocketed by 153.54% to $1.7 million in 2025.
  • Its last three reported values are $1.7 million in Q3 2025, $601908.2 for Q2 2025, and $1.0 million during Q1 2025.